GATEX
Price
$53.02
Change
+$0.01 (+0.02%)
Updated
Jul 24 closing price
Net Assets
7.25B
HDCEX
Price
$11.04
Change
-$0.01 (-0.09%)
Updated
Jul 24 closing price
Net Assets
57.98M
Interact to see
Advertisement

GATEX vs HDCEX

GATEX vs HDCEX Comparison Chart in %
View a ticker or compare two or three
VS
GATEX vs. HDCEX commentary
Jul 28, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GATEX is a Hold and HDCEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GATEX has more cash in the bank: 7.25B vs. HDCEX (58M). GATEX pays higher dividends than HDCEX: GATEX (0.18) vs HDCEX (0.04). GATEX was incepted earlier than HDCEX: GATEX (49 years) vs HDCEX (13 years). HDCEX (2.41) is less costly to investors than GATEX (0.97). HDCEX is a more actively managed with annual turnover of: 204.00 vs. GATEX (17.00). HDCEX has a lower initial minimum investment than GATEX: HDCEX (1000) vs GATEX (2500). HDCEX annual gain was more profitable for investors over the last year : 11.00 vs. GATEX (10.05). GATEX return over 5 years is better than : 35.95 vs. HDCEX (28.47).
GATEXHDCEXGATEX / HDCEX
Total Expense Ratio0.942.4139%
Annual Report Gross Expense Ratio0.972.4140%
Fund Existence49 years13 years-
Gain YTD3.9416.30263%
Front Load6%N/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets7.25B58M12,495%
Annual Yield % from dividends0.180.04457%
Returns for 1 year10.0511.0091%
Returns for 3 years34.8041.7883%
Returns for 5 years35.9528.47126%
Returns for 10 years82.8641.78198%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JARIX16.520.27
+1.66%
Easterly Global Real Estate I
JHLVX50.000.22
+0.44%
JHancock Fundamental Large Cap Core C
MVALX45.12-0.15
-0.33%
Meridian Contrarian Legacy
DWOAX18.94-0.09
-0.47%
BNY Mellon Research Growth A
EEMEX11.90-0.18
-1.49%
MFS Emerging Markets Equity Research R2